| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Autoimmune bullous diseases induced by cyclin-dependent kinase 4/6 inhibitors—first cohort from the EADV Task Force ‘Dermatology for Cancer Patients’
|
Ortiz-Brugués, A.
|
|
|
35 |
10 |
p. 915-917
|
artikel
|
| 2 |
Confirmation of large BRCA2 reversion deletions leading to reconstituted in-frame transcripts detected via circulating tumor DNA
|
Collier, K.A.
|
|
|
35 |
10 |
p. 917-919
|
artikel
|
| 3 |
Corrigendum to “Impact of chemoradiation in periampullary carcinoma after Whipple’s pancreatico-duodenectomy”
|
Rastogi, V.
|
|
|
35 |
10 |
p. 923
|
artikel
|
| 4 |
Corrigendum to “Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments”
|
Ros, J.
|
|
|
35 |
10 |
p. 922
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
35 |
10 |
p. iii
|
artikel
|
| 6 |
Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis
|
Martín-Lluesma, S.
|
|
|
35 |
10 |
p. 860-872
|
artikel
|
| 7 |
Exploiting the tumor microenvironment and tumor mechanobiology for the treatment of cancer cachexia
|
Papavassiliou, K.A.
|
|
|
35 |
10 |
p. 914-915
|
artikel
|
| 8 |
Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
|
Hübel, K.
|
|
|
35 |
10 |
p. 840-859
|
artikel
|
| 9 |
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
|
Di Federico, A.
|
|
|
35 |
10 |
p. 902-913
|
artikel
|
| 10 |
Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial
|
Lin, Z.Y.
|
|
|
35 |
10 |
p. 882-891
|
artikel
|
| 11 |
Optimizing Rectal Cancer Treatment: A Path Towards Personalization
|
Romesser, Paul B.
|
|
|
35 |
10 |
p. 831-835
|
artikel
|
| 12 |
Optimizing Tomorrow’s Drug Development with Project Optimus: Precision Dosing IS Precision Oncology
|
Subbiah, Vivek
|
|
|
35 |
10 |
p. 836-839
|
artikel
|
| 13 |
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing
|
Rowlands, C.F.
|
|
|
35 |
10 |
p. 892-901
|
artikel
|
| 14 |
Preserving momentum on next-generation sequencing for head and neck squamous cell carcinoma
|
Rossi, A.
|
|
|
35 |
10 |
p. 919-921
|
artikel
|
| 15 |
Table of Contents
|
|
|
|
35 |
10 |
p. i-ii
|
artikel
|
| 16 |
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
|
Conroy, T.
|
|
|
35 |
10 |
p. 873-881
|
artikel
|
Tijdschrift beschrijving